Lagemann G M, Yannes M P, Ghodadra A, Rothfus W E, Agarwal V
From the Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
AJNR Am J Neuroradiol. 2016 Apr;37(4):766-72. doi: 10.3174/ajnr.A4603. Epub 2015 Nov 26.
Cervical transforaminal epidural steroid injections are commonly performed for temporary pain relief or diagnostic presurgical planning in patients with cervical radiculopathy. Intravascular injection of steroids during the procedure can potentially result in cord infarct, stroke, and even death. CT-fluoroscopy allows excellent anatomic resolution and precise needle positioning. This study sought to determine the safest needle tip position during CT-guided cervical transforaminal epidural steroid injection as determined by the incidence of intravascular injection.
We retrospectively evaluated procedural imaging for consecutive single-site CT-fluoroscopic cervical transforaminal epidural steroid injection performed during a 13-month period. Intravascular injections were identified and classified by volume, procedure phase, vessel type, and needle tip position relative to the targeted neural foramen. ANOVA, Wilcoxon, or Pearson χ(2) testing was used to assess differences among groups as appropriate.
Intravascular injections occurred in 49/201 (24%) procedures. Of the intravascular injections, 13/49 (27%) were large, 10/49 (20%) were small, and 26/49 (53%) were trace volume. Sixteen of 49 (33%) intravascular injections occurred with a trial contrast dose; 27/49 (55%), with a steroid/analgesic cocktail; and 6/49 (12%), with both. Twenty-seven of 49 (55%) intravascular injections were likely venous, 22/49 (45%) were indeterminate, and none were likely arterial. The intravascular injection rate was significantly lower (P < .001) for the extraforaminal needle position (8/82, 10%) compared with junctional (27/88, 31%) and foraminal (14/31, 45%) needle tip positions.
An extraforaminal needle position for CT-guided cervical transforaminal epidural steroid injection decreases the risk of intravascular injection and therefore may be safer than other needle tip positions.
颈椎经椎间孔硬膜外类固醇注射常用于缓解颈椎神经根病患者的临时疼痛或进行术前诊断性规划。在此过程中类固醇血管内注射可能会导致脊髓梗死、中风甚至死亡。CT透视可提供出色的解剖分辨率和精确的针定位。本研究旨在通过血管内注射发生率来确定CT引导下颈椎经椎间孔硬膜外类固醇注射期间最安全的针尖位置。
我们回顾性评估了在13个月期间连续进行的单部位CT透视引导下颈椎经椎间孔硬膜外类固醇注射的程序影像。通过注射量、操作阶段、血管类型以及针尖相对于目标椎间孔的位置来识别和分类血管内注射。根据情况使用方差分析、威尔科克森检验或皮尔逊χ²检验来评估组间差异。
201例手术中有49例(24%)发生血管内注射。在血管内注射中,13/49(27%)为大量注射,10/49(20%)为少量注射,26/49(53%)为微量注射。49例血管内注射中有16例(33%)发生在试验性造影剂剂量时;27/49(55%)发生在类固醇/镇痛合剂注射时;6/49(12%)两者均有。49例血管内注射中有27例(55%)可能为静脉注射,22/49(45%)不确定,无动脉注射。与关节突(27/88,31%)和椎间孔(14/31,45%)针尖位置相比,椎间孔外针尖位置的血管内注射率显著更低(P <.001)(8/82,10%)。
CT引导下颈椎经椎间孔硬膜外类固醇注射采用椎间孔外针尖位置可降低血管内注射风险,因此可能比其他针尖位置更安全。